Behavioral Health Market Research Reports & Industry Analysis
Extraordinary advances have been made in the treatment of mental illness. An understanding of what causes some mental health disorders has led to greater sophistication in tailoring treatment to the underlying basis of each disorder. As a result, many mental health disorders can now be treated nearly as successfully as physical disorders. Most treatment methods for mental health disorders can be categorized as either somatic or psychotherapeutic. Somatic treatments include drug therapy and electroconvulsive therapy. Psychotherapeutic treatments include individual, group, or family and marital psychotherapy; behavior therapy techniques (such as relaxation training or exposure therapy); and hypnotherapy. Most studies suggest that for major mental health disorders, a treatment approach involving both drugs and psychotherapy is more effective than either treatment method used alone.
The psychotherapeutic drug industry continues to struggle through a morass of issues that are directly or indirectly affecting competition. Some hurdles recently faced by competitors in this market include advertising restrictions, label changes, and some general negative views about mental illness treatments. However, there have been considerable strides in many areas of the market including advanced delivery techniques, increased education and awareness efforts, and improved effectiveness.
Behavioral Health Industry Research & Market Reports
-
Autism Spectrum Disorder (ASD) - Market Insights, Epidemiology and Market Forecast-2027
... (ASD) in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan. The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size ... Read More
-
Psychiatric Hospitals in Australia - Industry Market Research Report
... size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares. Read More
-
Global Tardive Dyskinesia Treatment Market 2019-2023
... as schizophrenia, bipolar disorder, and other brain conditions. Technavio’s analysts forecast the Global Tardive Dyskinesia Treatment Market to grow at a CAGR of 4.44% during the period 2019-2023. Covered in this report The report covers ... Read More
-
Mental Health & Substance Abuse Clinics in the US - Industry Market Research Report
... to outpatient settings, a growing opioid epidemic and increased health insurance coverage, demand for the Mental Health and Substance Abuse Clinics industry has grown. The federal expansion of Medicaid as part of the Patient Protection ... Read More
-
Mental Health & Substance Abuse Services
... include Acadia Healthcare, Hazelden Betty Ford Foundation, and Spectrum Health Systems (all based in the US), along with the Centre for Addiction and Mental Health (Canada), and the Crossroads Centre (Antigua). COMPETITIVE LANDSCAPE Demand for ... Read More
-
Global Autism Spectrum Disorder Therapeutics Market 2018-2022
... as core and associated. Core symptoms include impairment of social interaction and communication while associated spectrums include sleep deficits, language disability, mood swings, and self-injury. Technavio’s analysts forecast the Global Autism Spectrum Disorder Therapeutics Market ... Read More
-
Global Depression Partnering 2012 to 2018
... in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology typeThe report provides understanding and access to the partnering deals and agreements entered into by ... Read More
-
Down Syndrome - Market Insights, Epidemiology and Market Forecast-2027
... United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Down syndrome ... Read More
-
Down Syndrome - Epidemiology Forecast-2027
... Spain, Italy, France and United Kingdom), and Japan. Geography Covered • The United States • EU5 (Germany, France, Italy, Spain and the United Kingdom) • Japan Study Period: 2016-2027 Down syndrome - Disease Understanding and ... Read More
-
Global Schizophrenia Partnering 2012 to 2018
... in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology typeThe report provides understanding and access to the partnering deals and agreements entered into by ... Read More
-
Mental Health & Substance Abuse Centers in the US - Industry Market Research Report
... illnesses. These establishments offer long-term housing, supervision and counseling services. Over the five years to 2018, the industry has grown in response to increased awareness of mental health issues and substance abuse diseases. Industry growth ... Read More
-
Family Counseling & Crisis Intervention Services in the US - Industry Market Research Report
... as well as an expanding budget for social services at the federal level. Over the five years to 2018, industry revenue is forecast to increase at an annualized rate of 1.7% to $34.7 billion, despite ... Read More
-
Depression and Anxiety Disorders Drug Development Pipeline Review, 2018
... as well as uncontrollable thoughts about the event. Treatment includes antidepressants and cognitive therapy. There are 38 products in development for this indication. OCD is characterized by unreasonable thoughts and fears (obsessions) that lead to ... Read More
-
Global Autism Disorder Treatment Market Research Report 2018
... market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Autism Disorder Treatment basics: ... Read More
-
Depression - Pipeline Review, H2 2018
Depression - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Depression - Pipeline Review, H2 2018, provides an overview of the Depression (Central Nervous Sy Read More
-
Behavioral Therapists in the US - Industry Market Research Report
... many individuals with behavioral health ailments also have coexisting physical health conditions. This factor strains the US healthcare system because behavioral issues can complicate patients' treatment for other medical conditions or amplify current medical issues. ... Read More
-
Alcohol Addiction - Pipeline Review, H2 2018
... System) pipeline landscape. Alcohol addiction refers to a psychological and physical dependency on alcohol. Symptoms include decreased involvement in extracurricular activities, depression, restlessness, inability to control drinking and violent behavior. Risk factors include age, family ... Read More
-
Psychotic Major Depression Global Clinical Trials Review, H1, 2018
... report provides top line data relating to the clinical trials on Psychotic Major Depression. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ... Read More
-
The 2019-2024 Outlook for Psychotherapeutic Tranquilizing Agents Excluding Phenothiazine Derivatives in the United States
... the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the ... Read More
-
The 2019-2024 Outlook for Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives in the United States
... the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the ... Read More
-
The 2019-2024 Outlook for Anxiety Disorder Therapeutics in the United States
... millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is of its state and ... Read More
-
The 2019-2024 Outlook for Anxiety Disorders and Depression Treatments in the United States
... States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is ... Read More
-
Binge Eating Disorder (BED): Opportunity Analysis and Forecasts to 2027
... Obsessive Compulsive Disorder (OCD). Key opinion leaders indicated that the selection of pharmacotherapy to treat Binge Eating Disorder (BED) is dependent on each patient’s complex combinations of symptoms. The majority of clinical development in Binge ... Read More
-
Depression Treatment Drugs Markets in China
... The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines ... Read More
-
Depression Treatment Drugs Industry Forecasts - China Focus
... expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in ... Read More
